Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4575-4579

  Meden, Harald ^a   Fattahi Meibodi, Arjang ^a   Osmers, Rüdiger ^a   Krauss, Thomas ^a   Kuhn, Walther ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cervical cancer; Chemotherapy; Prognosis; Wertheim's hysterectomy

Indexed keywords

CARBOPLATIN; IFOSFAMIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; IFOSFAMIDE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; SURVIVAL ANALYSIS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032422040     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Alvarez RD, Soong SJ, Kinney WK, Reid GC, Schray MF, Podratz KC et al: Identification of prognosic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early stage squamous carcinoma of the cervix. Gynecol Oncol 35: 130-5, 1989.
2. Thar T, Millon RR, Daly JW: Radiation treatment of carcinoma of the cervix. Semin Oncol 9: 299-311, 1982.
3. Petterson F (ed.): Carcinoma of the uterine cervix. In: Annual report on the results of treatment in gynecological cancer. FIGO 22: 51-63, 1994.
4. Friedlander M, Kaye S, Sullivan A, Atkinson A, Elliott P, Coppleson M, Houghton R, Solomon J, Green D, Russell P, Hudson CN, Langlands, Tattersall HN: Cervical carcinoma: A drug-experience with combined cisplatin, vinblastine and bleomycin therapy. Gynecol Oncol 16: 275-81, 1983.
5. Meanwell CA, Mould JJ, Blackledge G: Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 70: 727-30, 1986.
6. Cervellino JC, Araujo CE, Pirisi C: Ifosfamide and mesna at high doses for treatment of cancer of the cervix. Cancer Chemother Pharmacol 26: 51-3, 1990.
7. Coleman RE, Harper PG, Gallagher C: A phase II study of ifosphamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 18: 280-83, 1986.
8. DeVita VT, Wasserman TH, Young RC: Perspectives on research in gynecologic oncology. Cancer 38: 509-25, 1991.
9. Alberts DS, Garcia D, Mason-Liddil N: Cisplatin in advanced cancer of the cervix: An update. Semin Oncol 18: 11-24, 1991.
10. Lhomme C, Schreinerova M, Delorme T, Murawa-Durand S, Chazard M: Is there a place for chemotherapy in the initial treatment of cervical cancer? Bull Cancer Paris 83(4): 276-92, 1996.
11. Marcial VA, Marcial LV: Radiation therapy of cervical cancer: new developments. Cancer 71: 1438-1445, 1993.
12. Sardi J, Sananes C, Giaroli A, Bajo J, Rueda NG, Vighi S et al: Results of a prospective randomized trial with neoadjuvant chemotherapy in Stage Ib, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49: 156-165, 1993.
13. Friedlander ML, Atkinson K, Coppleson JV, Elliot P, Green D, Houghton R et al: The integration of chemotherapy into the management of locally advanced cervical cancer: a pilot study. Gynecol Oncol 19: 1-7, 1984.
14. Kim DS, Moon H, Hwang YY, Cho SH: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIIb with bulky tumour. Gynecol Oncol 29: 321-332, 1988.
15. Dottino PR, Plaxe SC, Beddoe AM, Johnston AC, Cohen CJ: Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 40: 7-11, 1991.
16. Benedetti Panici P, Scambia G, Baiocchi G, Greggi S, Ragusa G, Gallo A et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer 67(2): 372-379, 1991.
17. Sardi J, Sananes C, Giaroli A, Maya G, di Paola G: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38(3): 486-493, 1990.
18. Namkoong SG, Park JS, Kim JW, Bae SN, Han GT, Lee JM et al: Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 59: 136-142, 1995.
19. Eddy GL, Manetta A, Alvarex RD, Williams L, Creasman WT: Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage Ib bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol 57: 412-416, 1995.
20. Bolis G, van Zainten-Przybysz I, Scarfone G, Zanaboni F, Scarabelli C, Tateo S et al: Determinants of response to a cisplatin-based regime as neoadjuvant chemotherapy in stage Ib-IIb invasive cervical cancer. Gynecol Oncol 63: 62-65, 1996.